Ignite Creation Date:
2024-05-06 @ 12:53 AM
Last Modification Date:
2024-10-26 @ 10:56 AM
Study NCT ID:
NCT01687244
Status:
COMPLETED
Last Update Posted:
2017-07-24
First Post:
2012-09-06
Brief Title:
Intravesical Administration of rAd-IFNSyn3 in Patients With BCG-Refractory or Relapsed Bladder Cancer
Sponsor:
FKD Therapies Oy
Organization:
FKD Therapies Oy
Organization Data
Organization:
FKD Therapies Oy
Class:
INDUSTRY
Study ID:
rAd-IFN-CS-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
FKD Therapies Oy
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None